Acute Pain Market Outlook The high prevalence of severe pain, affecting approximately 17.6% of adults in the United States, is a significant driver behind the development of acute pain treatments. Acute pain is commonly managed with medications such as anti-seizure drugs, muscle relaxants, and opioids. There is an increasing focus on non-opioid